BECTON DICKINSON & CO — Director's Dealing 2021

Nov 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2021-11-26

Reporting Person: Hickey David (EVP & President, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-26	Common Stock	A	1473	$0.0	Acquired	5059	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-26	Rights to Common Stock Under 1996 Directors Deferral Plan	$	A	1511	Acquired		Common Stock (1511)	Direct
2021-11-26	Stock Appreciation Rights	$245.09	A	10522	Acquired	2031-11-26	Common Stock (10522)	Direct

Footnotes

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: The securities convert to common stock on a one-for-one basis.

F3: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F4: The stock appreciation rights vest in four annual installments beginning November 26, 2022.